Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kakoulidou

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Acta Neurologica Scandinavica|September 20, 2007
Treatment of a patient with myasthenia gravis using antibodies against CD25M Kakoulidou, R Pirskanen-Matell, A K Lefvert
Acta Neurologica Scandinavica|March 23, 2007
A clinical and immunological study of a myasthenia gravis patient treated with infliximabM Kakoulidou, S Bjelak, R Pirskanen, et al.
Journal of Internal Medicine|August 22, 2006
Characterization of the expanded T-cell populations in patients with Wegener's granulomatosisR Giscombe, X B Wang, M Kakoulidou, et al.
Journal of Internal Medicine|March 30, 2007
The soluble forms of CD28, CD86 and CTLA-4 constitute possible immunological markers in patients with abdominal aortic aneurysmP Sakthivel, V Shively, M Kakoulidou, et al.
Scandinavian Journal of Immunology|October 24, 2007
Human Soluble CD80 is generated by alternative splicing, and recombinant soluble CD80 binds to CD28 and CD152 influencing T-cell activationM Kakoulidou, R Giscombe, X Zhao, et al.
Journal of Neuroimmunology|February 21, 2004
The autoimmune T and B cell repertoires in monozygotic twins discordant for myasthenia gravisM Kakoulidou, R Ahlberg, Q Yi, et al.
Radiation Protection Dosimetry|September 11, 2001
Radon survey in Kalamata (Greece)A Geranios, M Kakoulidou, P Mavroidi, et al.
Genes and Immunity|February 22, 2002
CDS1 and promoter single nucleotide polymorphisms of the CTLA-4 gene in human myasthenia gravisX B Wang, M Kakoulidou, Q Qiu, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Acta Neurologica Scandinavica|September 20, 2007
Treatment of a patient with myasthenia gravis using antibodies against CD25M Kakoulidou, R Pirskanen-Matell, A K Lefvert
Acta Neurologica Scandinavica|March 23, 2007
A clinical and immunological study of a myasthenia gravis patient treated with infliximabM Kakoulidou, S Bjelak, R Pirskanen, et al.
Journal of Internal Medicine|August 22, 2006
Characterization of the expanded T-cell populations in patients with Wegener's granulomatosisR Giscombe, X B Wang, M Kakoulidou, et al.
Journal of Internal Medicine|March 30, 2007
The soluble forms of CD28, CD86 and CTLA-4 constitute possible immunological markers in patients with abdominal aortic aneurysmP Sakthivel, V Shively, M Kakoulidou, et al.
Scandinavian Journal of Immunology|October 24, 2007
Human Soluble CD80 is generated by alternative splicing, and recombinant soluble CD80 binds to CD28 and CD152 influencing T-cell activationM Kakoulidou, R Giscombe, X Zhao, et al.
Journal of Neuroimmunology|February 21, 2004
The autoimmune T and B cell repertoires in monozygotic twins discordant for myasthenia gravisM Kakoulidou, R Ahlberg, Q Yi, et al.
Radiation Protection Dosimetry|September 11, 2001
Radon survey in Kalamata (Greece)A Geranios, M Kakoulidou, P Mavroidi, et al.
Genes and Immunity|February 22, 2002
CDS1 and promoter single nucleotide polymorphisms of the CTLA-4 gene in human myasthenia gravisX B Wang, M Kakoulidou, Q Qiu, et al.
Pageof 1